Literature DB >> 26129839

MicroRNA-205 regulates ubiquitin specific peptidase 7 protein expression in hepatocellular carcinoma cells.

Liang Zhu1, Rong Liu1, Wei Zhang1, Sheng Qian1, Jian-Hua Wang1.   

Abstract

Ubiquitin specific peptidase 7 (UPS7) has a critical role in the development and progression of cancer, at least in part, through its regulation of p53 protein stability. However, its molecular determinants remain to be elucidated. In the present study, it was identified that microRNA‑205 (miR‑205) may negatively regulate UPS7 protein levels through targeting its 3'‑untranslated region in hepatocellular carcinoma (HCC) cells. As a result, miR‑205 mimics inhibited USP7 protein levels while antisense miR‑205 enhanced USP7 protein levels, thereby modulating the p53 signaling pathway and cell proliferation levels. In conclusion, the data presents a novel molecule for the dysregulated expression of USP7 in HCC, which may assist in elucidating mechanisms underlying the tumorigenesis of HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26129839     DOI: 10.3892/mmr.2015.3998

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.

Authors:  Jingjing Tian; Xibao Hu; Wei Gao; Jie Zhang; Ming Chen; Xinrong Zhang; Junhong Ma; Hongxia Yuan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.

Authors:  Furong Yu; Jie Liu; Weilei Dong; Jing Xie; Xia Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 3.  Research Progress of DUB Enzyme in Hepatocellular Carcinoma.

Authors:  Jie Zhao; Jinhui Guo; Yanan Wang; Qiancheng Ma; Yu Shi; Feng Cheng; Qiliang Lu; Wen Fu; Guangxiong Ouyang; Ji Zhang; Qiuran Xu; Xiaoge Hu
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

4.  Effect of miR-184 and miR-205 on the tumorigenesis of conjunctival mucosa associated lymphoid tissue lymphoma through regulating RasL10B and TNFAIP8.

Authors:  Yu-Zhen Li; Pei Mou; Ya Shen; Lian-Di Gao; Xin-Xin Chen; Rui-Li Wei
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

5.  Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms.

Authors:  Xujing Wang; Qiqi Zhang; Yongkun Wang; Huiren Zhuang; Bo Chen
Journal:  Med Sci Monit       Date:  2018-03-25

Review 6.  Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Soheil Madadi; Heidi Schwarzenbach; Massoud Saidijam; Reza Mahjub; Meysam Soleimani
Journal:  Cell Biosci       Date:  2019-11-12       Impact factor: 7.133

7.  Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance.

Authors:  Wei Zhang; Jingxin Zhang; Chenzhou Xu; Shiqing Zhang; Saiyan Bian; Feng Jiang; Wenkai Ni; Lishuai Qu; Cuihua Lu; Runzhou Ni; Yihui Fan; Mingbing Xiao; Jinxia Liu
Journal:  Cancer Cell Int       Date:  2020-01-28       Impact factor: 5.722

Review 8.  Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.

Authors:  Deniz Mortazavi; Behnoush Sohrabi; Meysam Mosallaei; Ziba Nariman-Saleh-Fam; Milad Bastami; Yaser Mansoori; Abdolreza Daraei; Sepideh Zununi Vahed; Shadan Navid; Zahra Saadatian; Tannaz Jamialahmadi; Yong Teng; Amirhossein Sahebkar
Journal:  J Oncol       Date:  2022-01-11       Impact factor: 4.375

9.  Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.

Authors:  Seemana Bhattacharya; Dipankar Chakraborty; Malini Basu; Mrinal K Ghosh
Journal:  Signal Transduct Target Ther       Date:  2018-06-29

Review 10.  DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer.

Authors:  Francesca Bufalieri; Ludovica Lospinoso Severini; Miriam Caimano; Paola Infante; Lucia Di Marcotullio
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.